A sequential cohort study evaluating single-agent KappaMab and KappaMab combined with lenalidomide and low-dose dexamethasone in relapsed and/or refractory kappa light chain-restricted multiple myeloma (AMaRC 01-16)
Andrew Spencer, Anna Kalff, J Shortt, Hang Quach, Craig Wallington-Gates, John Reynolds, Patricia Walker, Simon Harrison, Dunn Rosanne, Cameron Wellard
Research output: Contribution to journal › Article › peer-review
2Citations
(Scopus)
90Downloads
(Pure)
Fingerprint
Dive into the research topics of 'A sequential cohort study evaluating single-agent KappaMab and KappaMab combined with lenalidomide and low-dose dexamethasone in relapsed and/or refractory kappa light chain-restricted multiple myeloma (AMaRC 01-16)'. Together they form a unique fingerprint.